From new conferences and OCT systems to the links between pediatric uveitis and early-onset atopic dermatitis, these are the news stories and studies that caught our attention this week…
The FDA has approved roflumilast (ZORYVE) foam 0.3% for once-daily treatment of plaque psoriasis in patients aged 12 and older, including hard-to-treat scalp and body areas..
Applying topicals 2 to 3 times per week to previously affected areas—even when the skin appears clear—can reduce flare frequency and improve quality of life.
A hospital-derived strain of Pseudomonas aeruginosa was found to degrade medical plastic, use it as food, and form stronger biofilms, revealing new risks for device-related infections.
A large-scale study found semaglutide use was associated with reduced risks of amputation, chronic pain, and wound complications in patients with diabetes-related foot ulcers.